SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer
about
SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer
description
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
@en
klinisch onderzoek
@nl
name
SAFIR02_Breast - Efficacy of G ...... With Metastatic Breast Cancer
@en
SAFIR02_Breast - Efficacy of G ...... With Metastatic Breast Cancer
@nl
type
label
SAFIR02_Breast - Efficacy of G ...... With Metastatic Breast Cancer
@en
SAFIR02_Breast - Efficacy of G ...... With Metastatic Breast Cancer
@nl
prefLabel
SAFIR02_Breast - Efficacy of G ...... With Metastatic Breast Cancer
@en
SAFIR02_Breast - Efficacy of G ...... With Metastatic Breast Cancer
@nl
P6153
P1050
P3098
NCT02299999